The problem is to control which enantiomer you want to produce – a problem that has proved to be important in the pharmaceutical industry. Researchers at the University of Gothenburg have now come up with a new method to control the process.
“Organic chemists think that it’s impossible to create only one of the enantiomers without introducing some kind of optical activity into the reaction, but I’ve succeeded,” says Theonitsa Kokoli at the University of Gothenburg’s Department of Chemistry. “My method will allow the industry to produce the version they want without the use of a catalyst.”
The phenomenon of non-superimposable mirror-image molecular structures is known as chirality. The two enantiomers can be compared to a pair of hands; they are non-superimposable mirror images of each other. A consequence of the different properties in biological systems is that a molecule can behave either as Dr Jekyll or Mr Hyde. The different characteristics in the enantiomers can be harmless, like in the limonene molecule. One enantiomer smells like orange and the other like lemon.
Thalidomide is a good example of how different forms of the same molecule can have disastrous consequences. One of the enantiomers was calming and eased nausea in pregnant women, while the other caused serious damage to the foetus. The thalidomide catastrophe is one of the reasons that a lot of research is devoted to chirality, as it is absolutely vital to be able to control which form of the molecule that is produced. Research on chirality has resulted in several Nobel Prizes over the years.
In biomolecules like DNA and proteins only one of the enantiomers exists in nature. In contrast to biomolecules, the same does not apply when chiral compounds are created synthetically in the lab. Generally an equal amount of both enantiomers is produced. One way of creating an excess of one enantiomer is to use a chiral catalyst, but this only transfers the properties that are already present in the catalyst.“I’ve been working with absolute asymmetric synthesis instead, where optical activity is created,” says Kokoli. “This is considered impossible by many organic chemists. I’ve used crystals in my reactions, where the two forms have crystallised as separate crystals, which in itself is fairly unusual. The product that was formed after the reactions comprised just one enantiomer.”
While the results of Kokoli’s research are particularly significant for the pharmaceuticals industry, they can also be used in the production of flavourings and aromas.
The thesis has been successfully defended on May 6, 2011
First transcription atlas of all wheat genes expands prospects for research and cultivation
17.08.2018 | Leibniz-Institut für Pflanzengenetik und Kulturpflanzenforschung
Staying in Shape
16.08.2018 | Max-Planck-Institut für molekulare Zellbiologie und Genetik
New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference
Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...
Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...
Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.
When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...
Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.
Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....
Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.
Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...
08.08.2018 | Event News
27.07.2018 | Event News
25.07.2018 | Event News
17.08.2018 | Materials Sciences
17.08.2018 | Information Technology
17.08.2018 | Physics and Astronomy